{
  "disease_name": "Crigler-Najjar syndrome",
  "orpha_code": "205",
  "drugs": [
    {
      "name": "Modified mRNA encoding the UGT1A1 protein",
      "substance_url": "/en/drug/substance/480199?name=205&mode=orpha&region=&status=all",
      "substance_id": "480199",
      "regulatory_url": "/en/drug/regulatory/480201?name=205&mode=orpha&region=",
      "regulatory_id": "480201",
      "orpha_substance_code": "ORPHA:205",
      "details": [
        "Modified mRNA encoding the UGT1A1 protein(Medicinal product                        - 27/06/2016)Disease(s) concernedORPHA:205 Crigler-Najjar syndrome",
        "Modified mRNA encoding the UGT1A1 protein(Medicinal product                        - 27/06/2016)",
        "(Medicinal product                        - 27/06/2016)",
        "Disease(s) concernedORPHA:205 Crigler-Najjar syndrome",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/480199?name=205&mode=orpha&region=&status=all",
          "text": "Modified mRNA encoding the UGT1A1 protein",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/205",
          "text": "ORPHA:205 Crigler-Najjar syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/480201?name=205&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Adeno-associated viral vector serotype 8 containing the human UGT1A1 gene",
      "substance_url": "/en/drug/substance/406528?name=205&mode=orpha&region=&status=all",
      "substance_id": "406528",
      "regulatory_url": "/en/drug/regulatory/414159?name=205&mode=orpha&region=",
      "regulatory_id": "414159",
      "orpha_substance_code": "ORPHA:205",
      "details": [
        "Adeno-associated viral vector serotype 8 containing the human UGT1A1 gene(Medicinal product                        - 15/10/2014)Disease(s) concernedORPHA:205 Crigler-Najjar syndrome",
        "Adeno-associated viral vector serotype 8 containing the human UGT1A1 gene(Medicinal product                        - 15/10/2014)",
        "(Medicinal product                        - 15/10/2014)",
        "Disease(s) concernedORPHA:205 Crigler-Najjar syndrome",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/406528?name=205&mode=orpha&region=&status=all",
          "text": "Adeno-associated viral vector serotype 8 containing the human UGT1A1 gene",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/205",
          "text": "ORPHA:205 Crigler-Najjar syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/414159?name=205&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Heterologous human adult liver derived stem cells",
      "substance_url": "/en/drug/substance/102674?name=205&mode=orpha&region=&status=all",
      "substance_id": "102674",
      "regulatory_url": "/en/drug/regulatory/134180?name=205&mode=orpha&region=",
      "regulatory_id": "134180",
      "orpha_substance_code": "ORPHA:205",
      "details": [
        "Heterologous human adult liver derived stem cells(Medicinal product                        - 29/12/2007)Disease(s) concernedORPHA:205 Crigler-Najjar syndrome",
        "Heterologous human adult liver derived stem cells(Medicinal product                        - 29/12/2007)",
        "(Medicinal product                        - 29/12/2007)",
        "Disease(s) concernedORPHA:205 Crigler-Najjar syndrome",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/102674?name=205&mode=orpha&region=&status=all",
          "text": "Heterologous human adult liver derived stem cells",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/205",
          "text": "ORPHA:205 Crigler-Najjar syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/134180?name=205&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Adeno -associated viral vector serotype 8  containing the human functional version of UGT1A1 gene",
      "substance_url": "/en/drug/substance/516992?name=205&mode=orpha&region=&status=all",
      "substance_id": "516992",
      "regulatory_url": "/en/drug/regulatory/485026?name=205&mode=orpha&region=",
      "regulatory_id": "485026",
      "orpha_substance_code": "ORPHA:205",
      "details": [
        "Adeno -associated viral vector serotype 8  containing the human functional version of UGT1A1 gene(Medicinal product                        - 18/11/2016)Disease(s) concernedORPHA:205 Crigler-Najjar syndrome",
        "Adeno -associated viral vector serotype 8  containing the human functional version of UGT1A1 gene(Medicinal product                        - 18/11/2016)",
        "(Medicinal product                        - 18/11/2016)",
        "Disease(s) concernedORPHA:205 Crigler-Najjar syndrome",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/516992?name=205&mode=orpha&region=&status=all",
          "text": "Adeno -associated viral vector serotype 8  containing the human functional version of UGT1A1 gene",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/205",
          "text": "ORPHA:205 Crigler-Najjar syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/485026?name=205&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Adeno-associated viral vector serotype 8 containing the human UGT1A1 gene",
      "substance_url": "/en/drug/substance/406528?name=205&mode=orpha&region=&status=all",
      "substance_id": "406528",
      "regulatory_url": "/en/drug/regulatory/411882?name=205&mode=orpha&region=",
      "regulatory_id": "411882",
      "orpha_substance_code": "ORPHA:205",
      "details": [
        "Adeno-associated viral vector serotype 8 containing the human UGT1A1 gene(Medicinal product                        - 22/08/2014)Disease(s) concernedORPHA:205 Crigler-Najjar syndrome",
        "Adeno-associated viral vector serotype 8 containing the human UGT1A1 gene(Medicinal product                        - 22/08/2014)",
        "(Medicinal product                        - 22/08/2014)",
        "Disease(s) concernedORPHA:205 Crigler-Najjar syndrome",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/406528?name=205&mode=orpha&region=&status=all",
          "text": "Adeno-associated viral vector serotype 8 containing the human UGT1A1 gene",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/205",
          "text": "ORPHA:205 Crigler-Najjar syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/411882?name=205&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "rAAV8-hUGT1A1",
      "substance_url": "/en/drug/substance/689451?name=205&mode=orpha&region=&status=all",
      "substance_id": "689451",
      "regulatory_url": "/en/drug/regulatory/689621?name=205&mode=orpha&region=",
      "regulatory_id": "689621",
      "orpha_substance_code": "ORPHA:205",
      "details": [
        "rAAV8-hUGT1A1(Medicinal product                        - 29/10/2024)Disease(s) concernedORPHA:205 Crigler-Najjar syndrome",
        "rAAV8-hUGT1A1(Medicinal product                        - 29/10/2024)",
        "(Medicinal product                        - 29/10/2024)",
        "Disease(s) concernedORPHA:205 Crigler-Najjar syndrome",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/689451?name=205&mode=orpha&region=&status=all",
          "text": "rAAV8-hUGT1A1",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/205",
          "text": "ORPHA:205 Crigler-Najjar syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/689621?name=205&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Burixafor",
      "substance_url": "/en/drug/substance/689505?name=205&mode=orpha&region=&status=all",
      "substance_id": "689505",
      "regulatory_url": "/en/drug/regulatory/689915?name=205&mode=orpha&region=",
      "regulatory_id": "689915",
      "orpha_substance_code": "ORPHA:565779",
      "details": [
        "Burixafor(Medicinal product                        - 22/10/2024)Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "Burixafor(Medicinal product                        - 22/10/2024)",
        "(Medicinal product                        - 22/10/2024)",
        "Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/689505?name=205&mode=orpha&region=&status=all",
          "text": "Burixafor",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/565779",
          "text": "ORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/689915?name=205&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for transplant or complication after transplantation\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Treosulfan",
      "substance_url": "/en/drug/substance/90799?name=205&mode=orpha&region=&status=all",
      "substance_id": "90799",
      "regulatory_url": "/en/drug/regulatory/136690?name=205&mode=orpha&region=",
      "regulatory_id": "136690",
      "orpha_substance_code": "ORPHA:565779",
      "details": [
        "Treosulfan(Medicinal product                        - 08/04/2015)Disease(s) concernedORPHA:213500 Rare ovarian cancerORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "Treosulfan(Medicinal product                        - 08/04/2015)",
        "(Medicinal product                        - 08/04/2015)",
        "Disease(s) concernedORPHA:213500 Rare ovarian cancerORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/90799?name=205&mode=orpha&region=&status=all",
          "text": "Treosulfan",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/213500",
          "text": "ORPHA:213500 Rare ovarian cancer",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/565779",
          "text": "ORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/136690?name=205&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for transplant or complication after transplantation\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "busulfan",
      "substance_url": "/en/drug/substance/46335?name=205&mode=orpha&region=&status=all",
      "substance_id": "46335",
      "regulatory_url": "/en/drug/regulatory/131973?name=205&mode=orpha&region=",
      "regulatory_id": "131973",
      "orpha_substance_code": "ORPHA:565779",
      "details": [
        "busulfan(Medicinal product                        - 21/04/1994)Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "busulfan(Medicinal product                        - 21/04/1994)",
        "(Medicinal product                        - 21/04/1994)",
        "Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/46335?name=205&mode=orpha&region=&status=all",
          "text": "busulfan",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/565779",
          "text": "ORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/131973?name=205&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for transplant or complication after transplantation\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    }
  ],
  "processing_timestamp": "2025-07-07T06:04:37.154792",
  "run_number": 1,
  "total_drugs_found": 9,
  "search_url": "https://www.orpha.net/en/drug?diseaseName=Crigler-Najjar+syndrome&orphaCode=205&name=205&region=&mode=orpha&status=all",
  "search_params": {
    "diseaseName": "Crigler-Najjar syndrome",
    "orphaCode": "205",
    "name": "205",
    "region": "",
    "mode": "orpha",
    "status": "all"
  }
}